Company news
Crescita Therapeutics, Inc. news in 2020
Crescita Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
November 26, 2020
Crescita Reports Third Quarter 2020 Results
November 12, 2020
Crescita Announces Licensing Agreement for Pliaglis® in China
November 5, 2020
Crescita Reports Second Quarter 2020 Results
August 12, 2020
Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing Agreement
July 28, 2020
Crescita Reports First Quarter 2020 Results
May 27, 2020
Crescita Therapeutics Announces the Results of its Annual General Meeting of Shareholders
May 14, 2020
Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19
April 28, 2020
Crescita Therapeutics Announces Measures in Response to COVID-19 Virus
March 24, 2020
Crescita Reports Q4 and Fiscal 2019 Results
March 18, 2020
Pliaglis® finally available in Canada
March 10, 2020
Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patients with Plaque Psoriasis
February 11, 2020
Crescita Awarded Cannabis Research License from Health Canada
January 24, 2020
Crescita Secures Line of Credit with the Royal Bank of Canada Following Repayment in Full of Knight Therapeutics Loan
January 22, 2020
Crescita Signs Exclusive Distribution Agreement with FILLMED
January 20, 2020